348150 — KoBioLabs Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for KoBioLabs, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-55,072	-15,382	-23,030	-14,683	-4,178
Depreciation
Amortisation
Non-Cash Items	45,355	656	4,609	-3,063	-2,176
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-3,263	2,013	958	2,398	-580
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-12,771	-12,481	-16,556	-13,832	-4,355
Capital Expenditures	-276	-5,551	-14,765	-15,562	-1,646
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	21,267	-25,603	-47,049	23,754	8,081
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	20,992	-31,154	-61,814	8,192	6,434
Financing Cash Flow Items	—	—	—	-9.89	-7.48
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	31,045	55,741	36,310	4,046	-6,513
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	39,348	12,066	-42,260	-386	-4,358